4.6 Article

Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

The 2007 WHO classification of tumours of the central nervous system

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2007)

Article Clinical Neurology

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss

Constance A. Griffin et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)

Article Oncology

Manifestation, mechanisms and mysteries of gene amplifications

S Myllykangas et al.

CANCER LETTERS (2006)

Article Clinical Neurology

Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma

Y Arakawa et al.

ACTA NEUROPATHOLOGICA (2005)

Article Clinical Neurology

Characterization of the 1p/19q chromosomal loss in oligodendrogliomas using comparative genomic hybridization arrays (CGHa)

JK Cowell et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)

Article Genetics & Heredity

Detection of large-scale variation in the human genome

AJ Iafrate et al.

NATURE GENETICS (2004)

Article Oncology

Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target

MJ Riemenschneider et al.

INTERNATIONAL JOURNAL OF CANCER (2003)

Review Clinical Neurology

The WHO classification of tumors of the nervous system

P Kleihues et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)